OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance
Yu Sun, Dan Dong, Yuhong Xia, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 89
Yu Sun, Dan Dong, Yuhong Xia, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 89
Showing 1-25 of 89 citing articles:
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 82
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 82
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Qingmiao Shi, Chen Xue, Yifan Zeng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
Wanzun Lin, Li Chen, Haojiong Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Wanzun Lin, Li Chen, Haojiong Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 55
Yanan Qi, Zhu Liu, Lian‐Lian Hong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 55
The structure and function of YTHDF epitranscriptomic m6A readers
Vilbert Sikorski, Simona Selberg, Maciej Łałowski, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 335-353
Open Access | Times Cited: 54
Vilbert Sikorski, Simona Selberg, Maciej Łałowski, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 335-353
Open Access | Times Cited: 54
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
Exploring extracellular RNA as drivers of chemotherapy resistance in cancer
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Advances in targeting RNA modifications for anticancer therapy
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 28
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 28
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 22
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 22
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
The role and mechanism of m6A methylation in diabetic nephropathy
Lin-Jing Yan, Liang Guo
Life Sciences (2025) Vol. 363, pp. 123355-123355
Closed Access | Times Cited: 1
Lin-Jing Yan, Liang Guo
Life Sciences (2025) Vol. 363, pp. 123355-123355
Closed Access | Times Cited: 1
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Interplay of m6A RNA methylation and gut microbiota in modulating gut injury
Haixia Wang, Juanjuan Han, Xinan Zhang
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Haixia Wang, Juanjuan Han, Xinan Zhang
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
The Potential Role of m6A RNA Methylation in the Aging Process and Aging-Associated Diseases
Jin Sun, Bokai Cheng, Yongkang Su, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 30
Jin Sun, Bokai Cheng, Yongkang Su, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 30
YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis
Junlong Zhu, Hang Tong, Yan Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6905-6905
Open Access | Times Cited: 20
Junlong Zhu, Hang Tong, Yan Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 6905-6905
Open Access | Times Cited: 20
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Weiwei Liu, Zhongyuan Zhang, Fei Wang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Weiwei Liu, Zhongyuan Zhang, Fei Wang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer
Yanan Zhu, Jing Li, Hang Yang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Yanan Zhu, Jing Li, Hang Yang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Single‐cell transcriptome sequencing reveals SPP1 ‐CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
Fuzhong Liu, Junfeng Zhang, Xiaowei Gu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 7
Fuzhong Liu, Junfeng Zhang, Xiaowei Gu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 7
Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer
Shang Chen, Yan He, Xin Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Shang Chen, Yan He, Xin Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Reading the m6A-encoded epitranscriptomic information in development and diseases
Yunbing Chen, Ziyu Zhou, Yanxi Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Yunbing Chen, Ziyu Zhou, Yanxi Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
Emerging role of E2F8 in human cancer
Da Young Lee, Jung Nyeo Chun, Minsoo Cho, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166745-166745
Open Access | Times Cited: 14
Da Young Lee, Jung Nyeo Chun, Minsoo Cho, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166745-166745
Open Access | Times Cited: 14
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
Chenlin Liu, Fan Dong, Jiahui Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Chenlin Liu, Fan Dong, Jiahui Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
